Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Olmesartan Medoxomil and Amlodipine Besylate Tablets

Approval Number

国药准字H20223672

Company国药集团致君（深圳）坪山制药有限公司

Registration Date

September 14, 2022

Drug Information

Generic Name

奥美沙坦酯氨氯地平片

Dosage Form

片剂

Strength

每片含奥美沙坦酯20mg与苯磺酸氨氯地平5mg (按氨氯地平计)

Drug Type

化学药品

Registration Date

September 14, 2022

Company Information

Applicant Company

Company Name国药集团致君（深圳）坪山制药有限公司

Company Address

深圳市坪山新区青兰三路18号

Manufacturing Company

Company Name

吉林省德商药业股份有限公司;国药集团致君(深圳)坪山制药有限公司

Company Address

吉林省辉南县经济开发区北一街;深圳市坪山新区青兰三路18号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy